This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: University of California. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Zev Wainberg: Innovator in Cancer Therapy
Introduction
Zev Wainberg is a prominent inventor based in Los Angeles, CA. He has made significant contributions to the field of cancer research through his innovative work on antibodies that target specific cancer-related proteins. His research aims to improve diagnosis and treatment options for patients suffering from various forms of cancer.
Latest Patents
Wainberg holds a patent for "Antibodies against cancer target block tumor growth, angiogenesis and metastasis." This invention provides antibodies that specifically target the first-third domains of N-cadherin and the fourth domain of N-cadherin. The patent outlines methods for diagnosis and treatment utilizing these antibodies, which are crucial for addressing cancers related to N-cadherin. He has 1 patent to his name.
Career Highlights
Zev Wainberg is affiliated with the University of California, where he conducts his research. His work has garnered attention for its potential to revolutionize cancer therapy and improve patient outcomes. His dedication to advancing medical science is evident in his innovative approaches to cancer treatment.
Collaborations
Wainberg collaborates with Robert E. Reiter, a fellow researcher in the field. Their combined expertise enhances the quality and impact of their research efforts.
Conclusion
Zev Wainberg's contributions to cancer research through his innovative patents and collaborations highlight his commitment to improving healthcare. His work continues to pave the way for advancements in cancer diagnosis and treatment.